RIGL Rigel Pharmaceuticals Inc

P/E 2.894

Forward P/E 9.29

Price/Sales 3.248

Beta 1.187

Div Yield --

Market Cap --

Company Analysis

Latest News

November 04, 2026

Rigel Pharmaceuticals Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026

Rigel Pharmaceuticals Inc. is projected to report third-quarter 2026 revenue of $80.10 million and a consensus EPS of $0.87, with shares currently trading near...